Japan stock market week to Jan 5, 2009

12 January 2009

Tokyo extended an advance in the three reporting weeks ended January 5. The Nikkei 225 was up 4.4%, recovering the 9,000 mark at the close for  the first time in two months, while the Topix index rose 3.4%. Over the  whole of 2008, Tokyo posted a year-on-year 42.1% plunge, while the  pharmaceutical sector outperformed the market with a 20.5% decline,  signifying its defensive nature. During this review period, stocks moved  in a relatively narrow range as a result of calmness in currency  exchanges and a dearth of players due to the holiday season. Investors  continued to worry that major Japanese companies might revise downward  their full-year earnings guidance on the reporting of third-quarter  results at end-January. However, some believe such anxieties have  already been priced in. On the positive side, investors expected that  the economic stimulus package to be presented by the new US  administration could help improve the American economy. The  pharmaceutical index ended up 4.3%, performing in line with the market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight